News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Sumanta K. Pal: Thank you Metroll US for discussing cancer screening
Photo taken from Sumanta K. Pal/X
May 3, 2024, 06:06

Sumanta K. Pal: Thank you Metroll US for discussing cancer screening

Sumanta K. Pal, Co-director of City of Hope’s Kidney Cancer Program, shared a post on X:

“Thank you Metroll US for the opportunity to come by and discuss cancer screening!
Kudos on your tremendous growth and impressed with the wonderful culture you have developed within the company!”

Source: Sumanta K. Pal/X

cancer cancer screening City of Hope Metroll US OncoDaily Oncology patient care Sumanta K. Pal
Blog
Aug 26, 2024, 17:35
MD Anderson receives over $21.4 million in CPRIT funding to support research and launch new core facilities
Opinion
Aug 26, 2024, 17:23
Sachin Jain: Ageism in workspace goes all ways
Blog
Aug 26, 2024, 17:19
Improving cancer care in these challenging setting - Global Coalition for Radiotherapy
Blog
Aug 26, 2024, 17:14
PSMA expression is no exception - Prostate Cancer Foundation
Blog
Aug 26, 2024, 17:07
Living Beyond Breast Cancer is thrilled to partner with Paxman Scalp Cooling to host Navigating Treatment Related Side Effects
Blog
Aug 26, 2024, 17:03
ASCO GU Cancers Symposium is Now Accepting Research
Blog
Aug 26, 2024, 16:59
Stryder's Journey with Stage 4 High-Risk NeuroBlastoma - St. Baldrick's Foundation
Blog
Aug 26, 2024, 16:46
Richard Scolyer: Proud to represent Australia in the Triathlon Multisport World Championships
Blog
Aug 26, 2024, 16:41
Justin du Toit: The first ever CAR NK cellular therapy in South Africa
Blog
Aug 26, 2024, 15:43
Oncoinfluencers to Follow on Social Media: Dr. Vanina Laurent-Ledru
Blog
Aug 26, 2024, 15:41
Final Week to apply for European Hematology Association CRTH
Insight
Aug 26, 2024, 15:39
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment